-
Outlook Therapeutics (NASDAQ:OTLK) Receives Buy Rating from HC Wainwright
Source: Buzz FX / 18 Jan 2025 05:51:16 America/New_York
Outlook Therapeutics (NASDAQ:OTLK) Receives Buy Rating from HC Wainwright Written by MarketBeat January 18, 2025 Share Link copied to clipboard. HC Wainwright reiterated their buy rating on shares of Outlook Therapeutics ( NASDAQ:OTLK - Fre
Read more...